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1   Realization that normal cells substantially contribute to the growth, angiogenesis, 
metastasis and therapy resistance is a game changer in understanding cancer and opens new 
possibilities for more successful cancer treatment. This thesis
2   Treatment with chemotherapy, radiotherapy or VEGF/VEGFR targeting agents upregulates 
CXCR4 and CXCL12 in several tumor types, stimulating tumor cell survival and enhancing 
tumor invasiveness and metastatic potential. This thesis
3   The expression of CXCR4 and CXCL12 in the nuclei of cancer and stromal cells suggests 
that, besides classical autocrine and paracrine signaling routes, an alternative intracrine 
CXCR4/CXCL12 signaling is active in cancer. This thesis
4   The sensitizing action of the CXCR4 inhibitor AMD3100 relies on two mechanisms: local 
disruption of pro-survival stromal signaling and mobilization of cancer cells to the circulating 
blood. This thesis
5   A limited success in translating promising results from the preclinical CXCR4 research in 
solid tumors reflects the vast complexity of the matter. This thesis
6   Cancer metastasis and leukocyte trafficking share chemokine-directed migration 
mechanisms. This thesis
7   The heterogeneity and plasticity of the tumor microenvironment remain the major 
challenge in overcoming the therapy resistance in solid tumors. This thesis
8   In cancer, as in life, understanding the context is the key to understand the consequences. 
Mary Helen Barcellos-Hoff, Nature Reviews, 2005 
9   It is a good morning exercise for a research scientist to discard a pet hypothesis every day 
before breakfast. Konrad Lorenz
10   Every job demands sacrifice. The key is to avoid unnecessary sacrifice. Sheryl Sandberg, 
Lean in: women, work and the will to lead.  2013
11   Poland has radically improved its education results in the past ten years, despite having 
a significant child poverty rate. Rigor is the theme and the driving force behind this success. 
Amanda Ripley, The smartest kids in the world and how they got that way, 2013
12   Rise early. One seldom regrets having made an early start, but one always regrets having 
set off too late. Gaston Rebuffat, On snow and rock, 1959
13   Practicing research is so much like climbing mountains – it is all about passion, struggle, 
persistence and good routine. And when you finally made it – the crystal-clear moment 
crowns the day – and then you realize you are still only half way.
Urszula Domanska
Groningen, 9th of December 2013
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